A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

The Mayo research team found that the combination of cytology and FISH raised the detection rate of bile duct and pancreatic cancer from 20 percent to 43 percent. "Bile duct and pancreatic cancers ...

T1 Tumor is ≤2cm in maximum diameter and confined to pancreas. T2 Tumor is >2cm and confined to pancreas. T3 Tumor extends beyond pancreas but does not involve celiac axis or superior mesenteric ...

A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science ...

A retrospective chart review was performed of patients with pancreatic cancer treated at the Johns Hopkins Hospital between January 2021 and December 2023. During their initial clinic visit, patients ...

pancreatic cysts and pancreatic cancer, among others. We also specialize in managing the complex complications associated with pancreatitis, such as necrotizing pancreatitis, fluid collections, ductal ...

Basal cell carcinoma, for example, has a five-year survival rate of 100%. Pancreatic ductal adenocarcinoma, however, has a five-year survival rate of just 4%. Carcinoma is curable if detected early.